DMCRX
Price
$18.18
Change
-$0.39 (-2.10%)
Updated
Oct 17 closing price
Net Assets
477.01M
NRGSX
Price
$62.80
Change
+$0.25 (+0.40%)
Updated
Oct 17 closing price
Net Assets
8.71B
Interact to see
Advertisement

DMCRX vs NRGSX

Header iconDMCRX vs NRGSX Comparison
Open Charts DMCRX vs NRGSXBanner chart's image
Driehaus Micro Cap Growth
Price$18.18
Change-$0.39 (-2.10%)
VolumeN/A
Net Assets477.01M
Neuberger Berman Genesis R6
Price$62.80
Change+$0.25 (+0.40%)
VolumeN/A
Net Assets8.71B
DMCRX vs NRGSX Comparison Chart in %
View a ticker or compare two or three
VS
DMCRX vs. NRGSX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DMCRX is a Hold and NRGSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NRGSX has more cash in the bank: 8.71B vs. DMCRX (477M). DMCRX pays higher dividends than NRGSX: DMCRX (1.77) vs NRGSX (0.06). DMCRX was incepted earlier than NRGSX: DMCRX (12 years) vs NRGSX (13 years). DMCRX (1.37) is less costly to investors than NRGSX (0.74). DMCRX is a more actively managed with annual turnover of: 116.00 vs. NRGSX (13.00). NRGSX has a lower initial minimum investment than DMCRX: NRGSX (0) vs DMCRX (10000). DMCRX annual gain was more profitable for investors over the last year : 30.09 vs. NRGSX (-10.12). DMCRX return over 5 years is better than : -2.12 vs. NRGSX (-2.32).
DMCRXNRGSXDMCRX / NRGSX
Total Expense Ratio1.370.74185%
Annual Report Gross Expense Ratio1.370.74185%
Fund Existence12 years13 years-
Gain YTD30.229-3.902-775%
Front LoadN/AN/A-
Min. Initial Investment100000-
Min. Initial Investment IRAN/AN/A-
Net Assets477M8.71B5%
Annual Yield % from dividends1.770.062,730%
Returns for 1 year30.09-10.12-297%
Returns for 3 years69.245.901,173%
Returns for 5 years-2.12-2.3291%
Returns for 10 years62.7010.24612%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JFNAX73.750.46
+0.63%
Janus Henderson Global Life Sciences A
GGCCX102.840.38
+0.37%
Gabelli Growth C
GMCUX16.770.04
+0.24%
Goldman Sachs Small/Mid Cap Equity R6
RLEFX38.980.04
+0.10%
American Funds American Balanced R5E
MSECX11.320.01
+0.09%
Morgan Stanley Inst International Eq C